BEAM vs. DBRG

In the year-to-date period, BEAM achieves a -36.17% return, which is significantly lower than DBRG's -1.84% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and DigitalBridge Group, Inc. (DBRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BEAM Sharpe Ratio is -0.47, which is lower than the DBRG Sharpe Ratio of -0.34. The chart below compares the historical Sharpe Ratios of BEAM and DBRG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BEAM has not paid dividends to shareholders, while DBRG's dividend yield for the trailing twelve months is around 0.36%.

The maximum BEAM drawdown since its inception was -89.12%, roughly equal to the maximum DBRG drawdown of -91.71%. Use the drawdown chart below to compare losses from any high point for BEAM and DBRG.

Beam Therapeutics Inc. (BEAM) and DigitalBridge Group, Inc. (DBRG) have volatilities of 24.72% and 24.86%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Beam Therapeutics Inc. and DigitalBridge Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.